Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Capital Reinvestment Ratio
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Capital Reinvestment Ratio of 2.24x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥47.07 Million) in capital expenditures (CN¥105.31 Million). See Suzhou Fushilai Pharmaceutical Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suzhou Fushilai Pharmaceutical Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Suzhou Fushilai Pharmaceutical Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. For live market cap and broader valuation context, see Suzhou Fushilai Pharmaceutical Co. Ltd. stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | CN¥47.07 Million | CN¥105.31 Million | ▲ +409.4% |
| 2023 | 0.44x | CN¥94.77 Million | CN¥41.62 Million | ▲ +32.5% |
| 2022 | 0.33x | CN¥151.19 Million | CN¥50.11 Million | ▼ -18.0% |
| 2021 | 0.40x | CN¥199.73 Million | CN¥80.75 Million | ▲ +2.7% |
| 2020 | 0.39x | CN¥166.85 Million | CN¥65.69 Million | ▼ -16.4% |
| 2019 | 0.47x | CN¥150.55 Million | CN¥70.93 Million | — |